Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 1031-1036, March 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ørntoft, T. F.
Right arrow Articles by Wolf, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ørntoft, T. F.
Right arrow Articles by Wolf, H.

The Blood Group ABO Gene Transcript Is Down-Regulated in Human Bladder Tumors and Growth-stimulated Urothelial Cell Lines1

Torben F. Ørntoft2, Peter Meldgaard, Bent Pedersen and Hans Wolf

Department of Clinical Biochemistry, Aarhus University Hospital [T. F. Ø.], and Department of Cytogenetics, Danish Cancer Society, Aarhus Amtssygehus, Tage Hansengade 2, DK 8000 Aarhus C [B. P.], and Department of Urology, Aarhus University Hospital, Skejby, DK 8200 Aarhus N [P. M., H. W.], Denmark

The molecular mechanism that in human bladder tumors leads to the loss of blood group ABO glycosyltransferase activity and, thereby, the loss of ABO antigens was investigated. In 15 tumors and 3 normal biopsies from blood group AB individuals and 7 tumors and 3 normal biopsies from blood group O individuals, mRNA was detected by a reverse transcription PCR (RT-PCR) assay, and the ABO blood group structure was determined by immunohistology. The RT-PCR spanned several introns in the ABO gene to exclude DNA contamination, and the RT-PCR product was shown to reflect the ABO gene message by dideoxy sequencing. The ABO mRNA was present in normal urothelium and low-grade tumors but disappeared from high grade tumors. This correlation to tumor grade was significant (P < 0.04). Immunohistochemistry with monoclonal anti-blood group antibodies showed a complete correlation between the presence of mRNA and the presence of AB carbohydrate structures on cell surfaces. In two urothelial cell lines, genotyped as A/- and A/A, growth stimulation with the cholera toxin B subunit led to a total loss of ABO mRNA, and epidermal growth factor stimulation had an identical effect on one of the cell lines. We conclude that the ABO glycosylation in normal and malignant urothelium is regulated at the mRNA level, and that a mechanism associated with cell proliferation may trigger down-regulation of ABO mRNA.

1 This work was supported by the Danish Cancer Research Fund; the Danish Cancer Society; the Blood Donor Foundation; the NOVO-Nordic Foundation; the Institute of Experimental Clinical Research, Aarhus University; the Clinical Oncology Trial Unit, Danish Cancer Society, Aarhus; and Legatstiftelsen Pedersholm.

2 To whom requests for reprints should be addressed, at Department of Clinical Biochemistry, Aarhus Amtssygehus, Tage Hansengade 2, DK 8000 Aarhus C, Denmark.

Received 9/26/95. Accepted 1/ 2/96.




This article has been cited by other articles:


Home page
JDRHome page
E. Dabelsteen and S. Gao
ABO Blood-group Antigens in Oral Cancer
Journal of Dental Research, January 1, 2005; 84(1): 21 - 28.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. H. Olesen, T. Thykjaer, and T. F. Orntoft
Mitotic checkpoint genes hBUB1, hBUB1B, hBUB3 and TTK in human bladder cancer, screening for mutations and loss of heterozygosity
Carcinogenesis, May 1, 2001; 22(5): 813 - 815.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
T Petretti, W Kemmner, B Schulze, and P M Schlag
Altered mRNA expression of glycosyltransferases in human colorectal carcinomas and liver metastases
Gut, March 1, 2000; 46(3): 359 - 366.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Kominato, Y. Hata, H. Takizawa, T. Tsuchiya, J. Tsukada, and F.-i. Yamamoto
Expression of Human Histo-blood Group ABO Genes Is Dependent upon DNA Methylation of the Promoter Region
J. Biol. Chem., December 24, 1999; 274(52): 37240 - 37250.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Kominato, T. Tsuchiya, N. Hata, H. Takizawa, and F.-i. Yamamoto
Transcription of Human ABO Histo-blood Group Genes Is Dependent upon Binding of Transcription Factor CBF/NF-Y to Minisatellite Sequence
J. Biol. Chem., October 10, 1997; 272(41): 25890 - 25898.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.